LIPOOTCPharmaceutical PreparationsFiscal year ends December 31
LIPELLA PHARMACEUTICALS INC.
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025
$0.00+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $2.27K
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Who owns Lipella Pharmaceuticals's shares
Held by institutions
–
Shares held, 13F filers
Institutional holders
–
Net institutional buying
–
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Jonathan H. Kaufman | See remarks below., Director, 10% owner | 898,849 | 19.45% | Apr 7, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Jonathan H. Kaufman See remarks below., Director, 10% owner | May 14, 2024 | Buy | +10,000 | $0.76 | $7.60K | 898,849 |
| Jonathan H. Kaufman See remarks below., Director, 10% owner | Mar 19, 2024 | Buy | +25,000 | $0.87 | $21.75K | 888,849 |
| Jonathan H. Kaufman See remarks below., Director, 10% owner | Mar 18, 2024 | Buy | +30,000 | $0.79 | $23.70K | 863,849 |
| Michael B. Chancellor Chief Medical Officer, Director, 10% owner | Mar 13, 2024 | Award | +144,906 | $0.69 | $99.99K | 877,637 |
| Jonathan H. Kaufman See remarks below., Director, 10% owner | Mar 13, 2024 | Award | +144,906 | $0.69 | $99.99K | 833,849 |
| Michael B. Chancellor Chief Medical Officer, Director, 10% owner | Dec 22, 2022 | Other | +22,950 | $5.75 | $131.96K | 732,730 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.